

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.76113626 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 7.74324440 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.57851029 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.57851029 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 7.43290894 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.24917859 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.24917859 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.76283313 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.51266755 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.05775837 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.05775837 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.05775837 |
| 13 | drug metabolic process (GO:0017144) | 6.04140921 |
| 14 | oxidative demethylation (GO:0070989) | 5.98415638 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.95766371 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.86870013 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.86669592 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.83217362 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.77939652 |
| 20 | urea metabolic process (GO:0019627) | 5.73765791 |
| 21 | urea cycle (GO:0000050) | 5.73765791 |
| 22 | tryptophan metabolic process (GO:0006568) | 5.71258236 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.63357043 |
| 24 | phenylpropanoid metabolic process (GO:0009698) | 5.55854864 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 5.52698321 |
| 26 | protein carboxylation (GO:0018214) | 5.45193087 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.45193087 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.42280273 |
| 29 | cysteine metabolic process (GO:0006534) | 5.36087104 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.35815540 |
| 31 | complement activation, alternative pathway (GO:0006957) | 5.35054437 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.27072555 |
| 33 | regulation of plasminogen activation (GO:0010755) | 5.16383328 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 5.12926541 |
| 35 | reverse cholesterol transport (GO:0043691) | 5.10606407 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 5.07494908 |
| 37 | bile acid metabolic process (GO:0008206) | 5.04076534 |
| 38 | regulation of complement activation (GO:0030449) | 5.03253288 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.97778363 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.97778363 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.97778363 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.94421173 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.92060400 |
| 44 | ethanol metabolic process (GO:0006067) | 4.84259257 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.82578405 |
| 46 | homocysteine metabolic process (GO:0050667) | 4.78730126 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.78111301 |
| 48 | phospholipid efflux (GO:0033700) | 4.75126798 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.70088768 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.70088768 |
| 51 | response to mercury ion (GO:0046689) | 4.68395319 |
| 52 | S-adenosylmethionine metabolic process (GO:0046500) | 4.67195092 |
| 53 | * negative regulation of hemostasis (GO:1900047) | 4.66228505 |
| 54 | * negative regulation of blood coagulation (GO:0030195) | 4.66228505 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 4.62244955 |
| 56 | alkaloid metabolic process (GO:0009820) | 4.60789107 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 4.60757782 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.60757782 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 4.58589111 |
| 60 | plasma lipoprotein particle clearance (GO:0034381) | 4.57530386 |
| 61 | lysine metabolic process (GO:0006553) | 4.51829898 |
| 62 | lysine catabolic process (GO:0006554) | 4.51829898 |
| 63 | cellular ketone body metabolic process (GO:0046950) | 4.44542899 |
| 64 | glycine metabolic process (GO:0006544) | 4.42918137 |
| 65 | cholesterol efflux (GO:0033344) | 4.38336711 |
| 66 | regulation of humoral immune response (GO:0002920) | 4.36643821 |
| 67 | bile acid and bile salt transport (GO:0015721) | 4.36387542 |
| 68 | hormone catabolic process (GO:0042447) | 4.32990652 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.31514649 |
| 70 | indolalkylamine metabolic process (GO:0006586) | 4.29545580 |
| 71 | coenzyme catabolic process (GO:0009109) | 4.26592193 |
| 72 | positive regulation of blood coagulation (GO:0030194) | 4.25784218 |
| 73 | positive regulation of hemostasis (GO:1900048) | 4.25784218 |
| 74 | cellular amino acid catabolic process (GO:0009063) | 4.24946616 |
| 75 | glutamate metabolic process (GO:0006536) | 4.24772660 |
| 76 | * negative regulation of coagulation (GO:0050819) | 4.23152128 |
| 77 | * negative regulation of wound healing (GO:0061045) | 4.21969344 |
| 78 | amine catabolic process (GO:0009310) | 4.20198567 |
| 79 | cellular biogenic amine catabolic process (GO:0042402) | 4.20198567 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 4.19036893 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 4.17509351 |
| 82 | cellular glucuronidation (GO:0052695) | 4.16841058 |
| 83 | fibrinolysis (GO:0042730) | 4.14539190 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 4.12649783 |
| 85 | arginine metabolic process (GO:0006525) | 4.07233320 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 4.06289902 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 4.06206346 |
| 88 | serine family amino acid biosynthetic process (GO:0009070) | 4.04147297 |
| 89 | aldehyde catabolic process (GO:0046185) | 4.03796533 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02875949 |
| 91 | ethanol oxidation (GO:0006069) | 3.97098894 |
| 92 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.96735265 |
| 93 | flavonoid metabolic process (GO:0009812) | 3.95802635 |
| 94 | drug catabolic process (GO:0042737) | 3.93385076 |
| 95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.92942435 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.92942435 |
| 97 | positive regulation of coagulation (GO:0050820) | 3.92663144 |
| 98 | polyketide metabolic process (GO:0030638) | 3.91198212 |
| 99 | doxorubicin metabolic process (GO:0044598) | 3.91198212 |
| 100 | daunorubicin metabolic process (GO:0044597) | 3.91198212 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.85961858 |
| 102 | ketone body metabolic process (GO:1902224) | 3.84741188 |
| 103 | negative regulation of lipase activity (GO:0060192) | 3.84366523 |
| 104 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.83112845 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.81719662 |
| 106 | cholesterol homeostasis (GO:0042632) | 3.81264315 |
| 107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.80427511 |
| 108 | cofactor catabolic process (GO:0051187) | 3.79201918 |
| 109 | plasma lipoprotein particle organization (GO:0071827) | 3.78876580 |
| 110 | regulation of lipoprotein particle clearance (GO:0010984) | 3.77609972 |
| 111 | protein-lipid complex assembly (GO:0065005) | 3.75600938 |
| 112 | complement activation, classical pathway (GO:0006958) | 3.75325845 |
| 113 | sterol homeostasis (GO:0055092) | 3.74861895 |
| 114 | steroid catabolic process (GO:0006706) | 3.73670685 |
| 115 | complement activation (GO:0006956) | 3.73457797 |
| 116 | carboxylic acid catabolic process (GO:0046395) | 3.71164048 |
| 117 | organic acid catabolic process (GO:0016054) | 3.71164048 |
| 118 | cytolysis (GO:0019835) | 3.70170729 |
| 119 | intestinal cholesterol absorption (GO:0030299) | 3.69769998 |
| 120 | uronic acid metabolic process (GO:0006063) | 3.69408629 |
| 121 | glucuronate metabolic process (GO:0019585) | 3.69408629 |
| 122 | * protein activation cascade (GO:0072376) | 3.67357550 |
| 123 | * blood coagulation, intrinsic pathway (GO:0007597) | 3.66412792 |
| 124 | regulation of bile acid biosynthetic process (GO:0070857) | 3.66021452 |
| 125 | acute-phase response (GO:0006953) | 3.64999558 |
| 126 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.61259808 |
| 127 | regulation of cholesterol homeostasis (GO:2000188) | 3.59432748 |
| 128 | short-chain fatty acid metabolic process (GO:0046459) | 3.59178375 |
| 129 | negative regulation of protein activation cascade (GO:2000258) | 3.58960443 |
| 130 | sodium-independent organic anion transport (GO:0043252) | 3.58799795 |
| 131 | acetyl-CoA metabolic process (GO:0006084) | 3.58471741 |
| 132 | xenobiotic metabolic process (GO:0006805) | 3.57515115 |
| 133 | heme transport (GO:0015886) | 3.57183328 |
| 134 | negative regulation of complement activation (GO:0045916) | 3.56715398 |
| 135 | primary alcohol catabolic process (GO:0034310) | 3.55162801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.41031128 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.21649923 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.98669415 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.52957658 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.33457127 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.16518772 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.89180271 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.09181947 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05015186 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08537561 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.02464762 |
| 12 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0350413 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96815468 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62311354 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58721565 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55560998 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49622423 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40825672 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34194719 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21637942 |
| 21 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.18550639 |
| 22 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17929483 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17473030 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17303554 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02513152 |
| 26 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02160245 |
| 27 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.99856875 |
| 28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99415084 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98188098 |
| 30 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.97404931 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92144388 |
| 32 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.91459337 |
| 33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90522216 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87160199 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86565497 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.86268962 |
| 37 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.85925565 |
| 38 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85141688 |
| 39 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84141028 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.84138827 |
| 41 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84058156 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83316991 |
| 43 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81700380 |
| 44 | NFYA_21822215_ChIP-Seq_K562_Human | 0.81419393 |
| 45 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80241110 |
| 46 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79939230 |
| 47 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.79923860 |
| 48 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.79882495 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79110486 |
| 50 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78762876 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76391787 |
| 52 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76270050 |
| 53 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.76165662 |
| 54 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.74029770 |
| 55 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.73892881 |
| 56 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72429457 |
| 57 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72361243 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71368642 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70852221 |
| 60 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70755156 |
| 61 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69184833 |
| 62 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.68919464 |
| 63 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.68571566 |
| 64 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.67606891 |
| 65 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66227886 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65877284 |
| 67 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.65681814 |
| 68 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.64723763 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64366995 |
| 70 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.64288677 |
| 71 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.63927512 |
| 72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63737319 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.63435310 |
| 74 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63406994 |
| 75 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.63271421 |
| 76 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.63245258 |
| 77 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.63055252 |
| 78 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.62582751 |
| 79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62139763 |
| 80 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62139763 |
| 81 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61607562 |
| 82 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.61162625 |
| 83 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.61101308 |
| 84 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.61096396 |
| 85 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60714672 |
| 86 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60659041 |
| 87 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.60646777 |
| 88 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.60240187 |
| 89 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.58113629 |
| 90 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.58109667 |
| 91 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57173701 |
| 92 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.56493502 |
| 93 | NFYB_21822215_ChIP-Seq_K562_Human | 0.55303930 |
| 94 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55229253 |
| 95 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.54281144 |
| 96 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.54078882 |
| 97 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.53856726 |
| 98 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53660902 |
| 99 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.53467852 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53151738 |
| 101 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52762818 |
| 102 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.52760548 |
| 103 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.52667280 |
| 104 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.52594222 |
| 105 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52463452 |
| 106 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.52043838 |
| 107 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51215360 |
| 108 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50923764 |
| 109 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50482777 |
| 110 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49959384 |
| 111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.47579938 |
| 112 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47270434 |
| 113 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46831698 |
| 114 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46788727 |
| 115 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46149242 |
| 116 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45152772 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.44756883 |
| 118 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43433881 |
| 119 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.42711093 |
| 120 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42670480 |
| 121 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42422952 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42202869 |
| 123 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41526529 |
| 124 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.41320019 |
| 125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40673627 |
| 126 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40119692 |
| 127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.40026713 |
| 128 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39292498 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38959027 |
| 130 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.38878863 |
| 131 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37513918 |
| 132 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37443262 |
| 133 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37297565 |
| 134 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.36509404 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.36092758 |
| 136 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35045165 |
| 137 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34909136 |
| 138 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.34509773 |
| 139 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33584702 |
| 140 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33570377 |
| 141 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.33233365 |
| 142 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.33156222 |
| 143 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33100215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.21514355 |
| 2 | MP0005360_urolithiasis | 7.54339876 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.42479195 |
| 4 | MP0005365_abnormal_bile_salt | 6.15916155 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.10832948 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.19081279 |
| 7 | MP0003252_abnormal_bile_duct | 3.86706381 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.65096031 |
| 9 | MP0009840_abnormal_foam_cell | 3.42153339 |
| 10 | MP0005083_abnormal_biliary_tract | 3.13344178 |
| 11 | MP0003195_calcinosis | 2.83710954 |
| 12 | MP0005332_abnormal_amino_acid | 2.76065361 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.57445327 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.52555799 |
| 15 | MP0000609_abnormal_liver_physiology | 2.19179337 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.16138411 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.10648934 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.97720914 |
| 19 | MP0003868_abnormal_feces_composition | 1.91531916 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82397506 |
| 21 | MP0001764_abnormal_homeostasis | 1.68849515 |
| 22 | MP0009697_abnormal_copulation | 1.63064398 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57122892 |
| 24 | MP0003011_delayed_dark_adaptation | 1.49606392 |
| 25 | MP0005451_abnormal_body_composition | 1.43952580 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.36736628 |
| 27 | MP0003186_abnormal_redox_activity | 1.27065004 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.23017396 |
| 29 | MP0000598_abnormal_liver_morphology | 1.20566027 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.15591376 |
| 31 | MP0000604_amyloidosis | 1.15079196 |
| 32 | MP0005647_abnormal_sex_gland | 1.10447636 |
| 33 | MP0004043_abnormal_pH_regulation | 1.09362851 |
| 34 | MP0002254_reproductive_system_inflammat | 1.07380523 |
| 35 | MP0009764_decreased_sensitivity_to | 1.06080709 |
| 36 | MP0009763_increased_sensitivity_to | 1.04129273 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.00723891 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.94143255 |
| 39 | MP0008469_abnormal_protein_level | 0.90021566 |
| 40 | * MP0009642_abnormal_blood_homeostasis | 0.87132714 |
| 41 | MP0005408_hypopigmentation | 0.85483965 |
| 42 | MP0005187_abnormal_penis_morphology | 0.83634438 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 0.81382705 |
| 44 | MP0005376_homeostasis/metabolism_phenot | 0.81124966 |
| 45 | MP0009765_abnormal_xenobiotic_induced | 0.79494160 |
| 46 | MP0001915_intracranial_hemorrhage | 0.79157764 |
| 47 | MP0005670_abnormal_white_adipose | 0.78489825 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 0.78067417 |
| 49 | MP0005084_abnormal_gallbladder_morpholo | 0.77919599 |
| 50 | MP0005220_abnormal_exocrine_pancreas | 0.73577453 |
| 51 | MP0002876_abnormal_thyroid_physiology | 0.72673458 |
| 52 | MP0003879_abnormal_hair_cell | 0.71918588 |
| 53 | MP0002971_abnormal_brown_adipose | 0.71550801 |
| 54 | MP0001661_extended_life_span | 0.69578553 |
| 55 | MP0009053_abnormal_anal_canal | 0.68108282 |
| 56 | MP0004130_abnormal_muscle_cell | 0.67927981 |
| 57 | MP0003690_abnormal_glial_cell | 0.67880107 |
| 58 | MP0005334_abnormal_fat_pad | 0.67780240 |
| 59 | MP0005535_abnormal_body_temperature | 0.65066161 |
| 60 | MP0000639_abnormal_adrenal_gland | 0.63609197 |
| 61 | MP0005266_abnormal_metabolism | 0.63418542 |
| 62 | MP0003329_amyloid_beta_deposits | 0.63396859 |
| 63 | MP0001756_abnormal_urination | 0.59822052 |
| 64 | MP0005464_abnormal_platelet_physiology | 0.59490550 |
| 65 | MP0005448_abnormal_energy_balance | 0.55535083 |
| 66 | MP0006035_abnormal_mitochondrial_morpho | 0.55152588 |
| 67 | MP0002282_abnormal_trachea_morphology | 0.52529901 |
| 68 | MP0005395_other_phenotype | 0.50567927 |
| 69 | MP0003718_maternal_effect | 0.47885082 |
| 70 | MP0002822_catalepsy | 0.46609169 |
| 71 | MP0003638_abnormal_response/metabolism_ | 0.46041249 |
| 72 | MP0008873_increased_physiological_sensi | 0.45635087 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.45386078 |
| 74 | MP0008874_decreased_physiological_sensi | 0.44353681 |
| 75 | MP0003436_decreased_susceptibility_to | 0.44006719 |
| 76 | MP0002928_abnormal_bile_duct | 0.43074300 |
| 77 | MP0003959_abnormal_lean_body | 0.42175195 |
| 78 | MP0003724_increased_susceptibility_to | 0.41945877 |
| 79 | MP0003075_altered_response_to | 0.41735354 |
| 80 | MP0005023_abnormal_wound_healing | 0.40954881 |
| 81 | MP0003953_abnormal_hormone_level | 0.40189553 |
| 82 | MP0002249_abnormal_larynx_morphology | 0.40089438 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 0.39919957 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 0.39381433 |
| 85 | MP0008872_abnormal_physiological_respon | 0.37896536 |
| 86 | MP0009672_abnormal_birth_weight | 0.37701040 |
| 87 | MP0005166_decreased_susceptibility_to | 0.37380194 |
| 88 | MP0005248_abnormal_Harderian_gland | 0.37256920 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.37051547 |
| 90 | MP0004883_abnormal_blood_vessel | 0.37044192 |
| 91 | MP0000566_synostosis | 0.36539138 |
| 92 | MP0010386_abnormal_urinary_bladder | 0.36313193 |
| 93 | MP0000249_abnormal_blood_vessel | 0.34207046 |
| 94 | MP0001243_abnormal_dermal_layer | 0.33903556 |
| 95 | MP0000579_abnormal_nail_morphology | 0.33716955 |
| 96 | MP0009785_altered_susceptibility_to | 0.32961905 |
| 97 | MP0004381_abnormal_hair_follicle | 0.32651846 |
| 98 | MP0002796_impaired_skin_barrier | 0.32639511 |
| 99 | MP0009115_abnormal_fat_cell | 0.32374425 |
| 100 | MP0009384_cardiac_valve_regurgitation | 0.31085358 |
| 101 | MP0000230_abnormal_systemic_arterial | 0.30654741 |
| 102 | MP0002168_other_aberrant_phenotype | 0.30123506 |
| 103 | MP0002970_abnormal_white_adipose | 0.29804543 |
| 104 | MP0001853_heart_inflammation | 0.29370886 |
| 105 | MP0001845_abnormal_inflammatory_respons | 0.29146670 |
| 106 | MP0006082_CNS_inflammation | 0.29074355 |
| 107 | MP0005164_abnormal_response_to | 0.28972215 |
| 108 | MP0001881_abnormal_mammary_gland | 0.28195337 |
| 109 | MP0002132_abnormal_respiratory_system | 0.25168817 |
| 110 | MP0005058_abnormal_lysosome_morphology | 0.24467091 |
| 111 | MP0002090_abnormal_vision | 0.24176238 |
| 112 | MP0000467_abnormal_esophagus_morphology | 0.22943946 |
| 113 | MP0005197_abnormal_uvea_morphology | 0.21339618 |
| 114 | MP0002135_abnormal_kidney_morphology | 0.20511588 |
| 115 | MP0003632_abnormal_nervous_system | 0.19495483 |
| 116 | MP0002089_abnormal_postnatal_growth/wei | 0.19374894 |
| 117 | MP0000920_abnormal_myelination | 0.19296941 |
| 118 | MP0001944_abnormal_pancreas_morphology | 0.19167623 |
| 119 | MP0001851_eye_inflammation | 0.18378211 |
| 120 | MP0004272_abnormal_basement_membrane | 0.14950733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.55028833 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.39570978 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.23157217 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.70198412 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.67037757 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.48819803 |
| 7 | Xanthomatosis (HP:0000991) | 6.35442887 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.61270233 |
| 9 | Complement deficiency (HP:0004431) | 5.35103394 |
| 10 | Joint hemorrhage (HP:0005261) | 4.94171465 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.93591008 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.63938220 |
| 13 | Hyperammonemia (HP:0001987) | 4.60691065 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.50394892 |
| 15 | Epidermoid cyst (HP:0200040) | 4.49989600 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.37399307 |
| 17 | Hyperglycinemia (HP:0002154) | 4.34382000 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.34326286 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24421630 |
| 20 | Ketosis (HP:0001946) | 4.21925533 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.14827778 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.14594120 |
| 23 | Fat malabsorption (HP:0002630) | 4.06638777 |
| 24 | Abnormality of complement system (HP:0005339) | 3.90803956 |
| 25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.85281956 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.84960499 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.84960499 |
| 28 | Hyperglycinuria (HP:0003108) | 3.84506934 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.84350481 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.83247929 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.64961209 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.64705002 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.36911347 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30723905 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.28212147 |
| 36 | Spontaneous abortion (HP:0005268) | 3.26285073 |
| 37 | Osteomalacia (HP:0002749) | 3.18104250 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.05382789 |
| 39 | Hepatocellular carcinoma (HP:0001402) | 3.04650690 |
| 40 | Hypochromic microcytic anemia (HP:0004840) | 3.03350637 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02952253 |
| 42 | Steatorrhea (HP:0002570) | 3.02240034 |
| 43 | Delayed CNS myelination (HP:0002188) | 3.01641514 |
| 44 | Ketoacidosis (HP:0001993) | 2.93181514 |
| 45 | Myocardial infarction (HP:0001658) | 2.90566605 |
| 46 | Hyperphosphaturia (HP:0003109) | 2.78698370 |
| 47 | Skin nodule (HP:0200036) | 2.78491275 |
| 48 | Metabolic acidosis (HP:0001942) | 2.74073210 |
| 49 | Acanthocytosis (HP:0001927) | 2.72743108 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.72511282 |
| 51 | Reduced antithrombin III activity (HP:0001976) | 2.64405714 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.61787401 |
| 53 | Lethargy (HP:0001254) | 2.59183976 |
| 54 | Glomerulonephritis (HP:0000099) | 2.56600333 |
| 55 | Glycosuria (HP:0003076) | 2.56157451 |
| 56 | Abnormality of urine glucose concentration (HP:0011016) | 2.56157451 |
| 57 | Vascular calcification (HP:0004934) | 2.54275891 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.53249123 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53249123 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.51041882 |
| 61 | Hypoglycemic seizures (HP:0002173) | 2.46382821 |
| 62 | Amyloidosis (HP:0011034) | 2.46197893 |
| 63 | Cholelithiasis (HP:0001081) | 2.44998307 |
| 64 | Purpura (HP:0000979) | 2.44047758 |
| 65 | Spastic diplegia (HP:0001264) | 2.43664441 |
| 66 | Cerebral edema (HP:0002181) | 2.43515214 |
| 67 | Gout (HP:0001997) | 2.43040834 |
| 68 | Cholecystitis (HP:0001082) | 2.42707771 |
| 69 | Abnormal gallbladder physiology (HP:0012438) | 2.42707771 |
| 70 | Mitral stenosis (HP:0001718) | 2.38259119 |
| 71 | Gingival bleeding (HP:0000225) | 2.38251538 |
| 72 | Irritability (HP:0000737) | 2.34846472 |
| 73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.34016101 |
| 74 | Neonatal onset (HP:0003623) | 2.32595224 |
| 75 | Increased circulating renin level (HP:0000848) | 2.30342200 |
| 76 | Cardiovascular calcification (HP:0011915) | 2.25608134 |
| 77 | Esophageal varix (HP:0002040) | 2.25569351 |
| 78 | Abnormal urine phosphate concentration (HP:0012599) | 2.24810217 |
| 79 | Fair hair (HP:0002286) | 2.23168989 |
| 80 | Menorrhagia (HP:0000132) | 2.22429345 |
| 81 | Malnutrition (HP:0004395) | 2.20013903 |
| 82 | Thrombophlebitis (HP:0004418) | 2.19290098 |
| 83 | Elevated alkaline phosphatase (HP:0003155) | 2.17271464 |
| 84 | Abnormality of vitamin metabolism (HP:0100508) | 2.16335319 |
| 85 | Poikilocytosis (HP:0004447) | 2.15222037 |
| 86 | Pancreatitis (HP:0001733) | 2.13723728 |
| 87 | Enlarged kidneys (HP:0000105) | 2.13013120 |
| 88 | Proximal tubulopathy (HP:0000114) | 2.09213223 |
| 89 | Brushfield spots (HP:0001088) | 2.08732281 |
| 90 | Sensorimotor neuropathy (HP:0007141) | 2.08066319 |
| 91 | Late onset (HP:0003584) | 2.05594028 |
| 92 | Vomiting (HP:0002013) | 2.04754267 |
| 93 | Arthropathy (HP:0003040) | 2.04573703 |
| 94 | Abnormality of the gallbladder (HP:0005264) | 2.02552230 |
| 95 | Abnormality of the Achilles tendon (HP:0005109) | 2.01898937 |
| 96 | Hemorrhage of the eye (HP:0011885) | 1.99749657 |
| 97 | Generalized aminoaciduria (HP:0002909) | 1.99354436 |
| 98 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99001381 |
| 99 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.98767412 |
| 100 | Opisthotonus (HP:0002179) | 1.97418417 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 1.94529545 |
| 102 | Metabolic alkalosis (HP:0200114) | 1.93133612 |
| 103 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91313848 |
| 104 | Rickets (HP:0002748) | 1.90212117 |
| 105 | Neonatal hypoglycemia (HP:0001998) | 1.87072765 |
| 106 | Bifid scrotum (HP:0000048) | 1.86938996 |
| 107 | Abnormal cartilage morphology (HP:0002763) | 1.86393130 |
| 108 | Hypophosphatemic rickets (HP:0004912) | 1.83467794 |
| 109 | Hypokalemic alkalosis (HP:0001949) | 1.82343185 |
| 110 | Alkalosis (HP:0001948) | 1.81134946 |
| 111 | Renal cortical cysts (HP:0000803) | 1.80659637 |
| 112 | Hydroxyprolinuria (HP:0003080) | 1.80488324 |
| 113 | Abnormality of proline metabolism (HP:0010907) | 1.80488324 |
| 114 | Nephritis (HP:0000123) | 1.80345881 |
| 115 | Elevated hepatic transaminases (HP:0002910) | 1.80188615 |
| 116 | Hypophosphatemia (HP:0002148) | 1.78578473 |
| 117 | Abnormal biliary tract physiology (HP:0012439) | 1.78549245 |
| 118 | Bile duct proliferation (HP:0001408) | 1.78549245 |
| 119 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77855444 |
| 120 | Increased serum ferritin (HP:0003281) | 1.76105025 |
| 121 | Status epilepticus (HP:0002133) | 1.75357694 |
| 122 | Gangrene (HP:0100758) | 1.73069897 |
| 123 | Reticulocytosis (HP:0001923) | 1.72597068 |
| 124 | Pulmonary embolism (HP:0002204) | 1.72396759 |
| 125 | Potter facies (HP:0002009) | 1.69423913 |
| 126 | Facial shape deformation (HP:0011334) | 1.69423913 |
| 127 | Abnormal platelet function (HP:0011869) | 1.68935332 |
| 128 | Impaired platelet aggregation (HP:0003540) | 1.68935332 |
| 129 | Joint swelling (HP:0001386) | 1.67854315 |
| 130 | Hyperactive renin-angiotensin system (HP:0000841) | 1.67821604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 8.11368468 |
| 2 | BCKDK | 7.24602597 |
| 3 | FGFR4 | 4.65041202 |
| 4 | SIK1 | 4.47610590 |
| 5 | ERN1 | 4.40466295 |
| 6 | OXSR1 | 4.38858599 |
| 7 | INSRR | 3.02220856 |
| 8 | TAOK3 | 3.01619747 |
| 9 | ERBB4 | 2.92603541 |
| 10 | MAP2K4 | 2.32608097 |
| 11 | PKN2 | 2.29418935 |
| 12 | MST1R | 2.17414086 |
| 13 | MAPK11 | 1.96022431 |
| 14 | FLT3 | 1.95356934 |
| 15 | PIK3CA | 1.90149838 |
| 16 | TRIB3 | 1.82251782 |
| 17 | PIK3CG | 1.78694385 |
| 18 | TYK2 | 1.73764040 |
| 19 | LATS1 | 1.64595822 |
| 20 | DAPK2 | 1.58289228 |
| 21 | WNK4 | 1.54966922 |
| 22 | PTK6 | 1.50299474 |
| 23 | ABL2 | 1.49502864 |
| 24 | NEK9 | 1.45705289 |
| 25 | NTRK3 | 1.42970296 |
| 26 | KDR | 1.39128925 |
| 27 | FGFR2 | 1.34569978 |
| 28 | FRK | 1.32602399 |
| 29 | PRPF4B | 1.31296263 |
| 30 | JAK2 | 1.25173103 |
| 31 | MAP3K12 | 1.14722605 |
| 32 | MAP3K7 | 1.14159442 |
| 33 | PINK1 | 1.13470991 |
| 34 | PRKAA2 | 1.12811865 |
| 35 | GRK6 | 1.12744767 |
| 36 | MAP2K3 | 1.11103774 |
| 37 | MAP3K2 | 1.08649821 |
| 38 | ERBB2 | 1.06972038 |
| 39 | TBK1 | 1.05313949 |
| 40 | JAK1 | 1.02117291 |
| 41 | MAPK4 | 1.00050779 |
| 42 | MAP3K10 | 0.97934153 |
| 43 | MYLK | 0.95874316 |
| 44 | MUSK | 0.94650961 |
| 45 | MAP3K14 | 0.90655150 |
| 46 | MAP3K3 | 0.90507180 |
| 47 | PRKCZ | 0.90073769 |
| 48 | MET | 0.89918093 |
| 49 | EPHB1 | 0.89439625 |
| 50 | STK39 | 0.86644679 |
| 51 | PDK2 | 0.86598364 |
| 52 | MAP3K11 | 0.82765631 |
| 53 | STK38L | 0.82484297 |
| 54 | PRKACA | 0.82411338 |
| 55 | EPHA3 | 0.81785202 |
| 56 | MAPK12 | 0.81776990 |
| 57 | NLK | 0.81451100 |
| 58 | PRKG1 | 0.80215107 |
| 59 | TIE1 | 0.79678384 |
| 60 | CDK6 | 0.79523123 |
| 61 | PRKACG | 0.78552126 |
| 62 | MAPK15 | 0.74353785 |
| 63 | SGK1 | 0.73996479 |
| 64 | CAMK2G | 0.72087259 |
| 65 | CAMKK2 | 0.70921650 |
| 66 | CSK | 0.69451440 |
| 67 | DYRK1B | 0.68964752 |
| 68 | GSK3A | 0.68368747 |
| 69 | CAMK1D | 0.68162937 |
| 70 | SCYL2 | 0.67475699 |
| 71 | MAP2K6 | 0.66405771 |
| 72 | PRKAA1 | 0.65221160 |
| 73 | FER | 0.65157356 |
| 74 | RIPK1 | 0.64805003 |
| 75 | CSNK1D | 0.63774584 |
| 76 | TGFBR2 | 0.63629653 |
| 77 | TNK2 | 0.63093484 |
| 78 | PRKCB | 0.60907396 |
| 79 | SGK3 | 0.60326775 |
| 80 | PTK2 | 0.58568777 |
| 81 | BLK | 0.56842391 |
| 82 | FGFR3 | 0.56712516 |
| 83 | CSF1R | 0.56310885 |
| 84 | MAPK7 | 0.55546251 |
| 85 | ZAP70 | 0.54064663 |
| 86 | IKBKE | 0.53383958 |
| 87 | RPS6KA3 | 0.51807525 |
| 88 | IRAK3 | 0.50875708 |
| 89 | PDPK1 | 0.50488565 |
| 90 | PRKCQ | 0.49283902 |
| 91 | CSNK1G1 | 0.47266214 |
| 92 | TAOK2 | 0.46563567 |
| 93 | GRK1 | 0.45754838 |
| 94 | MAP2K1 | 0.45667927 |
| 95 | MAP3K5 | 0.44973042 |
| 96 | CSNK1A1 | 0.44503474 |
| 97 | EPHA4 | 0.43826340 |
| 98 | IGF1R | 0.42790342 |
| 99 | CDK4 | 0.42633177 |
| 100 | SGK2 | 0.42597643 |
| 101 | PRKCG | 0.42056139 |
| 102 | RET | 0.41779364 |
| 103 | PBK | 0.40277591 |
| 104 | SRC | 0.39242947 |
| 105 | CSNK1E | 0.39224817 |
| 106 | PKN1 | 0.39050909 |
| 107 | MAP3K6 | 0.38730650 |
| 108 | STK38 | 0.38636416 |
| 109 | MTOR | 0.35964449 |
| 110 | BRSK2 | 0.35811408 |
| 111 | MAP3K13 | 0.35259673 |
| 112 | EGFR | 0.34585443 |
| 113 | STK16 | 0.34395716 |
| 114 | ICK | 0.34332255 |
| 115 | KSR2 | 0.33697377 |
| 116 | CASK | 0.33579486 |
| 117 | EIF2AK1 | 0.31987814 |
| 118 | CAMKK1 | 0.31697052 |
| 119 | PDK1 | 0.31475536 |
| 120 | CAMK4 | 0.31196265 |
| 121 | SGK223 | 0.30714517 |
| 122 | SGK494 | 0.30714517 |
| 123 | CSNK2A1 | 0.29127016 |
| 124 | CSNK2A2 | 0.28946121 |
| 125 | MAP3K1 | 0.26912959 |
| 126 | CSNK1G2 | 0.26063693 |
| 127 | PRKCA | 0.25920778 |
| 128 | LATS2 | 0.25212947 |
| 129 | MAP2K2 | 0.24253899 |
| 130 | CSNK1G3 | 0.23380206 |
| 131 | PAK3 | 0.23158616 |
| 132 | BMX | 0.20829904 |
| 133 | ABL1 | 0.20369869 |
| 134 | IRAK1 | 0.19415703 |
| 135 | PRKACB | 0.18838332 |
| 136 | CAMK1G | 0.17971118 |
| 137 | MAPK3 | 0.17956327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.47522352 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.73768274 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.46305427 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.32817777 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.13230871 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.79968989 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67611442 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65506274 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63866303 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56768804 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47552758 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35126019 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22316878 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12397805 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10767558 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.04653820 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93531061 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90055258 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89960405 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89856876 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88729046 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86674753 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.82771602 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80284189 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76984770 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74040272 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72013149 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69048079 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67166937 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62572635 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60723943 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60472730 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57755720 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53498889 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51525036 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.47023619 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43558514 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34734574 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34679172 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33076877 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32428794 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27157217 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24284431 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23271239 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19918157 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19700106 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.18864522 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13841035 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01815777 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01484857 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99483291 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98461893 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98365841 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96786531 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94444816 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89738608 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87796378 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83463612 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.79465362 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77935754 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70650975 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66322390 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64397043 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61314207 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53586543 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47394817 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45926721 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36555866 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.34167235 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.27150165 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26611237 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25590244 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25428083 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.22891718 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22140238 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22104955 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21876391 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16252906 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09825843 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02210117 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | -0.2470357 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2468014 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | -0.2448579 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2408193 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2310522 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2275904 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2174516 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2122483 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1995115 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1849577 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1797686 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | -0.1757267 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1742731 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1739663 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1673654 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1612781 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1548653 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1493835 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1435703 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1287774 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1145288 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1020178 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0994350 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0704933 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0582663 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | -0.0480748 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0454620 |
| 108 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0282374 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0007550 |

